Aprea Therapeutics, Inc.
SEC Filing List
APRE CIK: 0001781983
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B7 | Prospectus filed pursuant to Rule 424(b)(7) | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 05/15/2026 | |
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 05/13/2026 | |
| 8-K | Current report filing | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 05/13/2026 | |
| DEF 14A | Definitive proxy statements | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 04/30/2026 | |
| ARS | Annual report to security holders | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 04/30/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 04/30/2026 | |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 04/29/2026 | |
| SCHEDULE 13G/A | M2 COMPLIANCE LLC /fa | 04/27/2026 | |||
| S-3 | Registration statement for specified tra... | Aprea Therapeutics, Inc. | Toppan Merrill/FA | 04/22/2026 | |
| No record found. | |||||
| Load More | |||||
